Symbol: |
BCL2L13
|
Description: |
BCL2-like 13 (apoptosis facilitator) [Source:HGNC Symbol;Acc:17164]
|
Location: |
Chr22:18111621-18213388[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:194
Gene |
Compound |
Gen_sig |
Exp_pattern |
BCL2L13 |
NSC 676780 |
0.043 |
Down |
BCL2L13 |
NSC 677166 |
0.021 |
Up |
BCL2L13 |
NSC 677747 |
0.029 |
Up |
BCL2L13 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.002 |
Up |
BCL2L13 |
4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide |
0.004 |
Up |
BCL2L13 |
NSC 678153 |
0.018 |
Down |
BCL2L13 |
1H-Indole, 3,3'-(2,5-piperazinediyl)bis(6-bromo-, (+-)-, dihydrobromide |
0.036 |
Up |
BCL2L13 |
Pyrimidin-2-amine, 4-(2-hydroxy-4-methoxyphenyl)-6-phenyl- |
0.04 |
Up |
BCL2L13 |
Adenine, 9-[1,2-bis(ethoxycarbonyl)ethenyl]-, trans- |
0.032 |
Up |
BCL2L13 |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.019 |
Up |
BCL2L13 |
NSC 681026 |
0.032 |
Up |
BCL2L13 |
1,4,7,10-Tetraazacyclododecane-1,7-bis(methanephosphonicacid) |
0.041 |
Up |
BCL2L13 |
Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2-acetyl- |
0.046 |
Down |
BCL2L13 |
2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[3-(dimethylamino)- 1-oxopropoxy)-19-[(2-propenyl)amino]-,stereoisomer, hydrochloride |
0.044 |
Down |
BCL2L13 |
NSC 684438 |
0.004 |
Up |
Expression pattern: Sensitivity / Resistance
Total:13 Current:7
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:111
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|